Product Information
- 2,5,8,11-Tetraazatridecan-13-oic acid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-
- 5,8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oic acid
- N,N-bis(2-{(carboxymethyl)[2-(methylamino)-2-oxoethyl]amino}ethyl)glycine
- DTPA-BMA
Dtpa-bma is an anticancer agent that acts as a kinase inhibitor. It has been shown to induce apoptosis in cancer cells by inhibiting the activity of kinases, which are enzymes that play a key role in cell signaling pathways. Dtpa-bma is an analog of Chinese hamster ovary (CHO) cell-derived ghrelin and is excreted in urine. This drug is effective against various types of cancer, including human tumors, and has been shown to inhibit tumor growth in vivo. Dtpa-bma is formulated as a cellulose-based resin for use in chromatography purification processes.
Chemical properties
Technical inquiry about: 3D-UEA89595 Dtpa-bma
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
